Navigation Links
A 'LEAP' in controlling cardiac fibrillation
Date:7/14/2011

This release is available in German.

An international team of scientists from the Max Planck Institute for Dynamics and Self-Organization (Gttingen, Germany), Cornell University (Ithaca, New York) the Ecole Normale Suprieure de Lyon (France), the University Medicine Gttingen (Germany), the Rochester Institute of Technology (USA), and the Institut Non-Linaire de Nice (France) have developed a new low-energy method for terminating life-threatening cardiac fibrillation of the heart. They have shown that their new technique called LEAP (Low-Energy Anti-fibrillation Pacing) reduces the energy required for defibrillation by more than 80% as compared to the current conventional method. Their discovery opens the path for the painless therapy of life threatening cardiac fibrillation. The scientists describe their results in the current issue of Nature.

In a healthy heart, electrical pulses that propagate across the heart muscle in an orderly fashion control the organ's movements: at regular intervals the heart's ventricles and atria contract and relax again. In the case of cardiac arrhythmia, however, this does not work reliably. Here, electrical pulses may propagate throughout the heart chaotically, disabling the regular heartbeat and thus preventing the body from being properly supplied with blood. The most common cardiac arrhythmia is atrial fibrillation, which affects more than 10 million people in Europe and US.

For patients suffering from chronic atrial fibrillation there is one reliable solution: a defibrillation. A strong electric pulse, which patients perceive as painful and which can damage the surrounding tissue forces the heart back into its regular beating. The international team of scientists led by Stefan Luther from the Max Planck Institute and Flavio Fenton from Cornell University has proposed a new method. Using a cardiac catheter the researchers create a sequence of five weak electrical signals in the heart. "Only a few seconds later, the heart beats regularly again", says Luther describing the team's newest results.

Even though LEAP and standard defibrillation seem to work similarly at first sight, they initiate completely different processes within the heart. "The classic defibrillator works by using a very strong electric field that excites all cells of the organ. In contrast, LEAP uses low-energy pulses to synchronize the tissue", says Fenton. For a short moment they can no longer transmit any electrical signals; the chaotic activity is terminated. "Afterwards, the heart resumes its normal, regular beating. The situation can be compared to turning a malfunctioning computer off and on again," says Robert Gilmour from Cornell University.

The new method terminates the turbulent electric activity within the heart step by step. "Our most important allies are natural heterogeneities within the heart such as blood vessels, fatty tissue or fibrotic tissue", says Eberhard Bodenschatz from the Max Planck Institute. In experiments and computer simulations the researchers were able to show that these heterogeneities can act as the origins for synchronizing waves. "Quite weak electrical pulses suffice to stimulate the cells in these regions", says Alain Pumir from Lyon. With every additional pulse more heterogeneities are activated thus gradually suppressing chaotic activity. "The heterogeneities act as small control sites that once activated can "reprogram" the entire organ", adds Valentin Krinsky from Nice.

In principle, the results also apply for defibrillation of ventricular fibrillation, a life-threatening arrhythmia, which is terminated only by external and implantable defibrillators. For a large number of patients wearing implantable cardioverter-defibrillators (ICD) the new technique may eliminate pain, improve the success rate of treatment, prolong battery life and therefore reduce the need for surgical device exchanges.

"The development of LEAP is a groundbreaking result and an outstanding example of successful interdisciplinary collaboration between physicists and physician-scientists, with immediate impact on the development of novel therapies for life-threatening cardiac arrhythmias", says Markus Zabel from the University Center Gttingen. The ideas leading to LEAP were first developed by asking elementary physical questions about the interaction between electric field and cardiac tissue; the results of earlier theoretical work in physics, in particular in the French National Center for Scientific Research (CNRS), may be finding their way to clinics. Indeed, "we are working to get this to the patient as fast as possible", adds Gerd Hasenfuss, the head of the Heart Center Gttingen.


'/>"/>

Contact: Dr. Birgit Krummheuer
birgit.krummheuer@ds.mpg.de
49-551-517-6668
Max-Planck-Gesellschaft
Source:Eurekalert  

Related medicine news :

1. Researchers make the leap to whole-cell simulations
2. Lupus Treatment May Soon Take Leap Forward
3. Scientists make leap forward in early detection for Alzheimers and cancer
4. Leap forward in efforts to develop treatments for Huntingtons disease
5. Founder of the LEAP Foundation to be Honored for Haiti Aid Efforts at The Aesthetic Meeting 2010
6. New Lucian Leape Institute Report Finds That U.S. Medical Schools Are Falling Short in Teaching Physicians How to Provide Safe Patient Care
7. A step toward controlling Huntingtons disease?
8. Controlling partners suffer more conflict with sexual desire
9. Controlling brain circuits with light
10. Melatonin might help in controlling weight gain and preventing heart diseases associated with obesity
11. Studies Highlight Challenge of Controlling Resistant Bacteria in Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A 'LEAP' in controlling cardiac fibrillation
(Date:2/27/2017)... ... February 27, 2017 , ... This ... laser diffraction analysis as a tool to characterize particle size distributions in the ... obtain improved results and novel scientific findings. It describes methods of optimized and ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... new informational post on robotic hair transplantation. San Francisco residents may be confused ... Follicular Unit Transplantation (FUT) can sound similar. Either treatment can be used to ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
(Date:2/26/2017)... ARLINGTON, VA (PRWEB) , ... February 26, 2017 , ... ... Medicaid Managed Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, ... work with PerformCARE to use behavioral health analytics to improve Medicaid population health management. ...
(Date:2/24/2017)... ... February 24, 2017 , ... Houston dentist ... his office, Antoine Dental Center. Currently, patients can get single dental implants for ... but patients can learn more about these offers by contacting Antoine Dental Center. ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Israel and TAMPA, Fla. , Feb. ... emerging medical device company focused on developing cerebral ... applauds the members of the FDA,s Circulatory System ... their acknowledgement of the need for cerebral protection ... "The statements shared by this FDA panel ...
(Date:2/27/2017)... Feb. 27, 2017  Impax Laboratories, Inc. (NASDAQ: IPXL ) today ... Raymond James and Associates, 38 th ... 2017 in Orlando, FL. Cowen ... ET on March 7, 2017 in Boston, MA. ... 16, 2017 in Miami, FL. ...
(Date:2/27/2017)... 27, 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and ... , M.D., Ph.D., as President and Chief Executive Officer (CEO) ... 2017. Dr. Craig succeeds Richard Love , interim President ... Board of Directors.  Dr. Craig has over 20 years of ... US and Europe . "On ...
Breaking Medicine Technology: